Literature DB >> 12716934

Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals.

Tong Li1, Guojun Ma, Huaibin Cai, Donald L Price, Philip C Wong.   

Abstract

Recent studies indicate that nicastrin (NCT) and presenilins form functional components of a multimeric gamma-secretase complex required for the regulated intramembraneous proteolysis of Notch and beta-amyloid (Abeta) precursor protein (APP). To determine whether nicastrin is required for proteolytic processing of Notch and APP in mammals and the role of nicastrin in presenilin/gamma-secretase complex assembly, we generated nicastrin-deficient (NCT-/-) mice and derived fibroblasts from NCT-/- embryos. Nicastrin-null embryos died by embryonic day 10.5 and exhibited several patterning defects, including abnormal somite segmentation, phenotypes that are reminiscent of embryos lacking Notch1 or both presenilins. Importantly, secretion of Abeta peptides is abolished in NCT-/- fibroblasts, whereas it is reduced by approximately 50% in NCT+/- cells; the failure to generate Abeta peptides in NCT-/- cells is accompanied by destabilization of the presenilin/gamma-secretase complex and accumulation of APP-C-terminal fragments. Moreover, APP trafficking analysis in NCT-/- fibroblasts revealed a significant delay in the rate of APP reinternalization compared with that of control cells. Together, these results establish that nicastrin is an essential component of the multimeric gamma-secretase complex in mammals required for both gamma-secretase activity and APP trafficking and suggest that nicastrin may be a valuable therapeutic target for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716934      PMCID: PMC6742329     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1.

Authors:  Z Zhang; P Nadeau; W Song; D Donoviel; M Yuan; A Bernstein; B A Yankner
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

2.  Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells.

Authors:  A Herreman; L Serneels; W Annaert; D Collen; L Schoonjans; B De Strooper
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

3.  Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1.

Authors:  S S Huppert; A Le; E H Schroeter; J S Mumm; M T Saxena; L A Milner; R Kopan
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

4.  Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.

Authors:  W P Esler; W T Kimberly; B L Ostaszewski; T S Diehl; C L Moore; J Y Tsai; T Rahmati; W Xia; D J Selkoe; M S Wolfe
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

5.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.

Authors:  Y M Li; M T Lai; M Xu; Q Huang; J DiMuzio-Mower; M K Sardana; X P Shi; K C Yin; J A Shafer; S J Gardell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Authors:  M S Wolfe; W Xia; B L Ostaszewski; T S Diehl; W T Kimberly; D J Selkoe
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

7.  A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.

Authors:  B De Strooper; W Annaert; P Cupers; P Saftig; K Craessaerts; J S Mumm; E H Schroeter; V Schrijvers; M S Wolfe; W J Ray; A Goate; R Kopan
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

8.  Mice lacking both presenilin genes exhibit early embryonic patterning defects.

Authors:  D B Donoviel; A K Hadjantonakis; M Ikeda; H Zheng; P S Hyslop; A Bernstein
Journal:  Genes Dev       Date:  1999-11-01       Impact factor: 11.361

9.  Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.

Authors:  Y M Li; M Xu; M T Lai; Q Huang; J L Castro; J DiMuzio-Mower; T Harrison; C Lellis; A Nadin; J G Neduvelil; R B Register; M K Sardana; M S Shearman; A L Smith; X P Shi; K C Yin; J A Shafer; S J Gardell
Journal:  Nature       Date:  2000-06-08       Impact factor: 49.962

10.  Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.

Authors:  A Herreman; D Hartmann; W Annaert; P Saftig; K Craessaerts; L Serneels; L Umans; V Schrijvers; F Checler; H Vanderstichele; V Baekelandt; R Dressel; P Cupers; D Huylebroeck; A Zwijsen; F Van Leuven; B De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

View more
  67 in total

1.  In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.

Authors:  Ting Yang; Dilyara Arslanova; Xiaoyin Xu; Yue-Ming Li; Weiming Xia
Journal:  J Neurochem       Date:  2010-03-12       Impact factor: 5.372

2.  Activity-dependent alpha-cleavage of nectin-1 is mediated by a disintegrin and metalloprotease 10 (ADAM10).

Authors:  Jinsook Kim; Christina Lilliehook; Amanda Dudak; Johannes Prox; Paul Saftig; Howard J Federoff; Seung T Lim
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Nicastrin is required for amyloid precursor protein (APP) but not Notch processing, while anterior pharynx-defective 1 is dispensable for processing of both APP and Notch.

Authors:  Chen Hu; Linlin Zeng; Ting Li; Michael A Meyer; Mei-Zhen Cui; Xuemin Xu
Journal:  J Neurochem       Date:  2016-01-17       Impact factor: 5.372

4.  Cellular distribution of gamma-secretase subunit nicastrin in the developing and adult rat brains.

Authors:  A Kodam; K S Vetrivel; G Thinakaran; S Kar
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

5.  Conditional forebrain inactivation of nicastrin causes progressive memory impairment and age-related neurodegeneration.

Authors:  Katsuhiko Tabuchi; Guiquan Chen; Thomas C Südhof; Jie Shen
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

6.  Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components.

Authors:  Yun-wu Zhang; Wen-jie Luo; Hong Wang; Ping Lin; Kulandaivelu S Vetrivel; Fang Liao; Feng Li; Philip C Wong; Marilyn G Farquhar; Gopal Thinakaran; Huaxi Xu
Journal:  J Biol Chem       Date:  2005-02-11       Impact factor: 5.157

Review 7.  Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease.

Authors:  Daniel R Dries; Gang Yu
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

8.  Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.

Authors:  Kulandaivelu S Vetrivel; Xavier Meckler; Ying Chen; Phuong D Nguyen; Nabil G Seidah; Robert Vassar; Philip C Wong; Masaki Fukata; Maria Z Kounnas; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

9.  Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta.

Authors:  Kulandaivelu S Vetrivel; Xulun Zhang; Xavier Meckler; Haipeng Cheng; Sungho Lee; Ping Gong; Kryslaine O Lopes; Ying Chen; Nobuhisa Iwata; Ke-Jie Yin; Jin-Moo Lee; Angèle T Parent; Takaomi C Saido; Yue-Ming Li; Sangram S Sisodia; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

10.  Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes.

Authors:  Kulandaivelu S Vetrivel; Haipeng Cheng; William Lin; Takashi Sakurai; Tong Li; Nobuyuki Nukina; Philip C Wong; Huaxi Xu; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.